Ovarian hyperthecosis in the setting of portal hypertension.
Hepatocellular dysfunction and perturbed portal hemodynamics alter steroid metabolism. Men with liver disease have gynecomastia, although women similarly affected rarely show virilization. We report a 10-yr-old girl with portal hypertension and shunting associated with precocious puberty and ovarian hyperandrogenism. This was one of premature twin girls; neither had clitoromegaly or genital ambiguity. In one child, neonatal respiratory problems led to umbilical vein catheterization with subsequent development of portal hypertension. Pubic hair was first noted at age 6 yr, breasts at 7 yr, and severe acne and clitoromegaly at 10 yr. Baseline sex hormones were elevated: androstenedione (A), 413 ng/dL; testosterone (T), 226 ng/dL; and estradiol (E2), 160 pg/mL. Liver transaminases were within the normal range, however, the coagulation profile was mildly abnormal. Cosyntropin adrenal stimulation revealed no steroidogenic defect. Dexamethasone suppression reduced A and T slightly. LH-releasing hormone stimulation produced a pubertal rise in LH and FSH. Pelvic sonography showed a large right ovary with numerous follicles. Surgical exploration revealed symmetrically enlarged ovaries with dense capsules. Histology of ovarian wedge resections showed hyperthecosis; immunohistochemistry showed stromal cells expressing steroidogenic enzymes and proteins. One month postoperatively, A and T were unchanged from baseline, whereas E2 decreased to 56 pg/mL. A single dose of depot leuprolide acetate significantly reduced T. Subsequent treatment with oral contraceptives reduced T to 50 ng/dL, and cyclical menses occurred. We conclude that precocious puberty and ovarian hyperthecosis were induced in this young girl by elevated circulating levels of sex hormones, a consequence of portasystemic shunting and impaired hepatic steroid metabolism.
Speiser
P W
PW
Department of Pediatrics, North Shore University Hospital, New York University School of Medicine, Manhasset 11030, USA. speiser@nshs.edu
Susin
M
M
Sasano
H
H
Bohrer
S
S
Markowitz
J
J
D000735:Androstenedione / Q000097:blood; D002648:Child; D003276:Contraceptives, Oral / Q000627:therapeutic use; D004200:Diseases in Twins; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood; D006801:Humans; D017588:Hyperandrogenism / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D006975:Hypertension, Portal / Q000150:complications*; D007150:Immunohistochemistry; D016729:Leuprolide / Q000627:therapeutic use; D010049:Ovarian Diseases / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D010053:Ovary / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D011629:Puberty, Precocious / Q000209:etiology; D013739:Testosterone / Q000097:blood; D013799:Theca Cells / Q000473:pathology*
D003276:Contraceptives, Oral; D012739:Gonadal Steroid Hormones; D013739:Testosterone; D000735:Androstenedione; D016729:Leuprolide